Effect of 3-5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: FACS randomized controlled trial.

Effect of 3-5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: FACS randomized controlled trial.

Библиографические подробности
Главные авторы:	Mant, D, Perera, R, Gray, A, Rose, P, Fuller, A, Corkhill, A, George, S, Little, L, Regan, S, Mellor, J, Pugh, SA, Northover, J, Weaver, A, Barsoum, G, Tan, LT, Mortensen, N, Scholefield, J, Wasan, H, Ferry, D, Primrose, J
Формат:	Journal article
Опубликовано:	2013

Схожие документы

Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
по: Primrose, J, и др.
Опубликовано: (2014)

Scheduled use of CEA and CT follow-up to detect recurrence of colorectal cancer: 6-12 year results from the FACS randomised controlled trial
по: Pugh, SA, и др.
Опубликовано: (2018)

Follow-up after colorectal cancer surgery: Preliminary observational findings from the UK FACS trial
по: Primrose, J, и др.
Опубликовано: (2011)

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
по: Shinkins, B, и др.
Опубликовано: (2017)

Follow up after colorectal surgery (the FACS trial)
по: Corkhill, A, и др.
Опубликовано: (2004)

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
по: Bethany Shinkins, и др.
Опубликовано: (2017-01-01)

WHAT IS THE TRUE INCIDENCE OF METACHRONOUS COLORECTAL LIVER METASTASES? EVIDENCE FROM THE UK FACS (FOLLOW-UP AFTER COLORECTAL SURGERY) TRIAL (ISRCTN: 41458548)
по: Pugh, S, и др.
Опубликовано: (2012)

Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS randomized controlled trial
по: Pugh, SA, и др.
Опубликовано: (2016)

What is the incidence of resectable recurrence after surgery for primary colorectal cancer? Evidence from the UK FACS (Follow-up After Colorectal Surgery) trial
по: Pugh, S, и др.
Опубликовано: (2012)

CEA monitoring in colorectal cancer is not a waste of time.
по: Mant, D, и др.
Опубликовано: (2014)

A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
по: Mant, D, и др.
Опубликовано: (2017)

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial
по: Shinkins, B, и др.
Опубликовано: (2018)

Blood CEA levels for detecting recurrent colorectal cancer: A Diagnostic Test Accuracy Review.
по: Nicholson, B, и др.
Опубликовано: (2015)

A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
по: David Mant, и др.
Опубликовано: (2017-05-01)

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
по: Shinkins, B, и др.
Опубликовано: (2017)

Experiences of patients with false positive results from colorectal cancer screening.
по: Mant, D, и др.
Опубликовано: (1990)

Surveillance for recurrence of colorectal cancer--reply.
по: Primrose, J, и др.
Опубликовано: (2014)

CEA vaccines
по: Anchit Bhagat, и др.
Опубликовано: (2023-12-01)

Ethics of preventive medicine.
по: Kettner, J, и др.
Опубликовано: (1988)

Patient compliance with colorectal cancer screening in general practice.
по: Mant, D, и др.
Опубликовано: (1992)

Performance verification of the MIRI Imager flight model at CEA
по: Ronayette, S, и др.
Опубликовано: (2010)

Delay to CEA
по: Christopher Nwatuzor, и др.
Опубликовано: (2024-01-01)

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
по: Stern, N, и др.
Опубликовано: (2005)

Quantitative analysis of mammalian translation initiation sites by FACS‐seq
по: William L Noderer, и др.
Опубликовано: (2014-08-01)

Sorting Out the FACS: A Devil in the Details
по: William C. Hines, и др.
Опубликовано: (2014-03-01)

Selection and characterisation of Affimers specific for CEA recognition
по: Shazana Hilda Shamsuddin, и др.
Опубликовано: (2021-01-01)

Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
по: Verne, J, и др.
Опубликовано: (1993)

ORGANOMETALLIC PHOTOELECTROCHEMISTRY - OXIDATION OF FAC-TRICARBONYLCHLORO[BIS(DIPHENYLPHOSPHINO)METHANE]MANGANESE(I)
по: Compton, R, и др.
Опубликовано: (1993)

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
по: Reyes Gonzalez-Exposito, и др.
Опубликовано: (2019-04-01)

JOSE ROBERTO CEA
по: La Universidad
Опубликовано: (2018-07-01)

Thomas S. Monahan, III, MD, FACS (1975-2019)
по: Salvatore T. Scali, MD, и др.
Опубликовано: (2020-01-01)

Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol.
по: Karin Huizer, и др.
Опубликовано: (2017-01-01)

The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited.
по: Hunter, W, и др.
Опубликовано: (1991)

Updating dataset of measurements for the experimental CEA-beam benchmark structure subjected to one stochastic broadband excitation with dataset of measurements for the CEA-beam system subjected to two correlated or uncorrelated broadband random excitations
по: S. Talik, и др.
Опубликовано: (2022-08-01)

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
по: Bethany Shinkins, и др.
Опубликовано: (2017-04-01)

Application of a neural network to predict the FAC rate of NPP equipment
по: A.D. Vishnyakova, и др.
Опубликовано: (2016-03-01)

CEA 重组痘苗病毒对 CEA 阳性肿瘤的防治研究
по: 罗超权, и др.
Опубликовано: (2000-01-01)

Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
по: Nolan, K, и др.
Опубликовано: (1999)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
по: Seung E. Cha, и др.
Опубликовано: (2021-01-01)

FAC-1 : FRAMEWORK ALLIANCE CONTRACT
по: Association of Consultant Architects
Опубликовано: (2016)